ロード中...
Tyrosine kinase inhibitors: Multi-targeted or single-targeted?
Since in most tumors multiple signaling pathways are involved, many of the inhibitors in clinical development are designed to affect a wide range of targeted kinases. The most important tyrosine kinase families in the development of tyrosine kinase inhibitors are the ABL, SCR, platelet derived growt...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Baishideng Publishing Group Co., Limited
2011
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3095472/ https://ncbi.nlm.nih.gov/pubmed/21603317 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5306/wjco.v2.i2.80 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|